Gilead Sciences (GILD) News Today → Urgent dollar warning (From Stansberry Research) (Ad) Free Gild Stock Alerts $65.33 -0.18 (-0.27%) (As of 05/2/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMcAdam LLC Has $1.63 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - May 3 at 12:08 AMGilead Sciences Q1 Earnings Transcriptmarketbeat.com - May 2 at 7:06 AMGilead Sciences, Inc. (NASDAQ:GILD) Short Interest Updateamericanbankingnews.com - May 2 at 3:08 AMShhh! 3 Secret Biotech Stocks Flying Below Wall Street's Radarinvestorplace.com - May 1 at 2:38 PMGilead Sciences (NASDAQ:GILD) Price Target Lowered to $85.00 at Maxim Groupmarketbeat.com - May 1 at 8:32 AMNorden Group LLC Raises Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - April 30 at 2:27 PMAnalysts Conflicted on These Healthcare Names: Annovis Bio (ANVS), Gilead Sciences (GILD) and Omega Therapeutics (OMGA)markets.businessinsider.com - April 30 at 10:53 AMGilead Sciences: Hold Rating Justified Amid Stable Outlook and Upcoming Oncology Catalystsmarkets.businessinsider.com - April 30 at 10:53 AMGilead Sciences (NASDAQ:GILD) Price Target Lowered to $76.00 at Barclaysamericanbankingnews.com - April 30 at 6:34 AMStock Traders Purchase Large Volume of Gilead Sciences Call Options (NASDAQ:GILD)americanbankingnews.com - April 30 at 2:32 AMRaymond James & Associates Trims Stake in Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - April 29 at 11:30 PMGilead Sciences: First-Quarter Results Beat Estimatesfool.com - April 29 at 6:57 PMGilead Sciences: Hold Rating with Cautious Outlook Amidst Market Challenges and Growth Uncertaintiesmarkets.businessinsider.com - April 29 at 1:48 PMTraders Purchase Large Volume of Gilead Sciences Call Options (NASDAQ:GILD)marketbeat.com - April 29 at 1:01 PMBarclays Cuts Gilead Sciences (NASDAQ:GILD) Price Target to $76.00marketbeat.com - April 29 at 11:36 AMGilead Sciences, Inc. to Post FY2024 Earnings of $3.82 Per Share, Cantor Fitzgerald Forecasts (NASDAQ:GILD)americanbankingnews.com - April 29 at 2:44 AMGilead Sciences, Inc. (GILD) Q1 2024 Earnings Call Transcriptseekingalpha.com - April 29 at 12:53 AMPFG Investments LLC Purchases 27,709 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - April 29 at 12:15 AMGilead Sciences (NASDAQ:GILD) PT Lowered to $74.00americanbankingnews.com - April 28 at 5:44 AMTD Cowen Lowers Gilead Sciences (NASDAQ:GILD) Price Target to $85.00americanbankingnews.com - April 28 at 5:44 AMNeedham & Company LLC Reiterates "Hold" Rating for Gilead Sciences (NASDAQ:GILD)americanbankingnews.com - April 28 at 5:44 AMGilead Sciences (NASDAQ:GILD) PT Lowered to $78.00americanbankingnews.com - April 28 at 5:44 AMSector Gamma AS Has $30.98 Million Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - April 27 at 4:38 PMGilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lagsfinance.yahoo.com - April 27 at 1:37 PMGilead Sciences, Inc. Declares Quarterly Dividend of $0.77 (NASDAQ:GILD)marketbeat.com - April 27 at 11:15 AMGilead Sciences (NASDAQ:GILD) Sets New 52-Week Low at $65.61americanbankingnews.com - April 27 at 5:32 AMGilead Sciences (NASDAQ:GILD) Upgraded at StockNews.comamericanbankingnews.com - April 27 at 2:18 AMTruist Financial Reaffirms Their Hold Rating on Gilead Sciences (GILD)markets.businessinsider.com - April 26 at 10:36 PMBank Julius Baer & Co. Ltd Zurich Has $34.83 Million Stake in Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - April 26 at 8:17 PMMorgan Stanley Lowers Gilead Sciences (NASDAQ:GILD) Price Target to $78.00marketbeat.com - April 26 at 2:28 PMGilead Sciences Says FDA OK's Updated Label Of Biktarvy To Treat Pregnant People With HIV-1markets.businessinsider.com - April 26 at 12:34 PMGilead Gives Up Big Gains As Covid Drug Drives Its Beat — Againfinance.yahoo.com - April 26 at 12:34 PMGilead Sciences (NASDAQ:GILD) Receives "Hold" Rating from Needham & Company LLCmarketbeat.com - April 26 at 8:43 AMGilead: Q1 Earnings Snapshotwashingtonpost.com - April 26 at 7:34 AMGilead Sciences Inc (GILD) Q1 2024 Earnings Call Transcript Highlights: Key Financials and ...finance.yahoo.com - April 26 at 7:34 AMZacks Research Research Analysts Lower Earnings Estimates for Gilead Sciences, Inc. (NASDAQ:GILD)americanbankingnews.com - April 26 at 1:38 AMDow Inc. Q1 Earnings Summarymarkets.businessinsider.com - April 25 at 9:33 PMGilead’s quarterly loss is narrower than expectedmsn.com - April 25 at 9:33 PMGilead Sciences, Inc. 2024 Q1 - Results - Earnings Call Presentationseekingalpha.com - April 25 at 8:14 PMGILD Stock Earnings: Gilead Sciences Beats EPS, Beats Revenue for Q1 2024investorplace.com - April 25 at 8:11 PMGilead Sciences (NASDAQ:GILD) Releases Earnings Results, Beats Expectations By $0.17 EPSmarketbeat.com - April 25 at 7:01 PMGilead Beats Earnings Expectations After Rocky Quarterbarrons.com - April 25 at 5:49 PMGilead Sciences (NASDAQ:GILD) Updates FY 2024 Earnings Guidancemarketbeat.com - April 25 at 5:47 PMGilead Sciences Inc (GILD) Q1 2024 Earnings: Misses Analyst EPS Estimates Amid Significant ...gurufocus.com - April 25 at 5:04 PMGilead posts quarterly loss, revenue rises 5%reuters.com - April 25 at 4:11 PMGilead Sciences Announces First Quarter 2024 Financial Resultsbusinesswire.com - April 25 at 4:02 PMGilead Sciences (NASDAQ:GILD) Reaches New 12-Month Low at $65.61marketbeat.com - April 25 at 3:45 PMGilead Sciences Target of Unusually Large Options Trading (NASDAQ:GILD)marketbeat.com - April 25 at 1:11 PMAlaska Permanent Fund Corp Sells 25,031 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - April 25 at 10:02 AMQ1 2024 EPS Estimates for Gilead Sciences, Inc. (NASDAQ:GILD) Decreased by Analystmarketbeat.com - April 25 at 7:37 AM Get Gilead Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GILD and its competitors with MarketBeat's FREE daily newsletter. Email Address Dems have chosen Biden replacement? (Ad)On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election. See who it is HERE. GILD Media Mentions By Week GILD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GILD News Sentiment▼0.160.33▲Average Medical News Sentiment GILD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GILD Articles This Week▼5617▲GILD Articles Average Week Get Gilead Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GILD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SGEN News Today BIIB News Today AMGN News Today MRNA News Today ARGX News Today BNTX News Today HCA News Today GSK News Today MCK News Today ZTS News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GILD) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldThe AI stock to buy right nowStockEarningsHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceCould Your Accounts Be Frozen?Allegiance GoldUrgent Nvidia WarningAltimetry$5,000 Gold?Stansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gilead Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
